Health and Medical News and Resources

General interest items edited by Janice Flahiff

[News item] Canada paying more than double for common generic drugs, study says | Metro

Canada paying more than double for common generic drugs, study says | Metro.

From the 14 October article

Canada is paying more than double for six commonly used generic drugs compared with other developed countries because of a “highly unusual” purchasing plan, according to a new study released Tuesday.

Researchers found that through a mix of negotiations with drug companies and calls for tender, countries such as New Zealand, the United Kingdom and Germany are paying less than Canada for generic medications that treat everything from high blood pressure to depression. It’s all thanks to a model the author of the study, Amir Attaran, calls “a uniquely Canadian stupidity.”

The model implemented by the provinces and territories (except for Quebec) in April 2013 simply sets the price for the six generic drugs at 18 per cent of the price of the brand-name versions. At the time, the premiers, under the auspices of the Council of the Federation, said the six drugs represented 20 per cent of publicly funded spending on generic drugs and that the new spending plan was expected to save up to $100 million.

“The Canadian approach of setting a single price ceiling for multiple medicines is highly unusual,” says the study. “All other countries studied here have preferred competition or negotiation to varying extents.”

………..

October 16, 2014 Posted by | Health News Items | , , , , | Leave a comment

Generic Drugs Often Have Incorrect Safety Labeling, Study Suggests

English: Methylphenidate packages from several...

English: Methylphenidate packages from several german generic drug manufacturers. Deutsch: Methylphenidat-Arzneimittel diverser deutscher Generikahersteller. (Photo credit: Wikipedia)

 

From the 13 December 2012 article at ScienceNewsDaily

 

…The majority of generics showed relatively small differences across their labels, but nine percent showed differences of more than 10 side effects. Errors included out-of-date information, incomplete data and, in one case, information for the wrong drug altogether.

“Physicians frequently use labeling information, either directly or indirectly, to make prescribing decisions. They need to know about side effects, drug interactions and other safety issues,” said Regenstrief Institute investigator Jon Duke, M.D., M.S., assistant professor of medicine at the Indiana University School of Medicine, who led the study. “We found that generic drug labels may contain incomplete or incorrect safety information. Until this problem is resolved, physicians and patients should rely on brand drug labeling only, even when the patient is getting a generic version of a drug.”…

 

 

 

 

 

December 16, 2012 Posted by | Consumer Health, Consumer Safety | , , | Leave a comment

Why you should avoid the temptation of drug coupons

 

From the 10 December 2012 article by Kevin Pho at KevinMD.com

Why you should avoid the temptation of drug coupons

A version of this column was published on October 24th, 2012 in USA Today.

As the cost of prescription drugs soar, more patients are turning to online coupons or discount cards from drug companies or promotional offers in magazines. In the past year, it is estimated that 19 million Americans whom took prescription drugs used such incentives to save money. The healthcare industry has witnessed a five-fold increase since 2009, with 395 medications today offering a promotional savings program.

In most cases, drug coupons can expose patients to potentially higher long-term costs, increase health spending, and mainly exist to protect the profits of drug companies….

….“An individual patient who receives a coupon might not realize that, although that particular prescription may cost less that month, overall what it does is to raise costs for everyone, including themselves,” according to Susan Pisano, a spokeswoman for the industry trade group America’s Health Insurance Plans.

It is also important to consider that the terms of drug coupon programs are completely at the whim of drug manufacturers. Some limit how many times the coupons may be used. Others require patients to jump through hoops and regularly visit drug company websites in order to renew. Most patients are unaware of the potential privacy concerns, as they are usually required to divulge their personal information—sometimes including their home address and even part of their medical history—before receiving coupons or discount cards.

Worst of all, drug coupon programs can end abruptly. When this happens, patients whose chronic diseases are managed by expensive brand name drugs are left to financially fend for themselves. If they don’t proactively change their medication regimen to generic alternatives with their doctors, their annual drug costs can easily rise by several hundred dollars or more.  I’ve seen patients simply stop taking their drugs once their costs rise suddenly, which in the case of diabetes, hypertension or high cholesterol, can lead to severe, and more expensive medical complications….

……Patients should collaborate with their doctors and do the math. Most conditions can be treated just as effectively with less expensive generic medications. Even with drug coupons, co-pays for brand name drugs generally exceed those of generics.

For a very small minority of patients, drug coupons may make sense. It may make sense in the few diseases where only brand name drugs are effective or in cases of extreme financial hardship where even generic medications are unaffordable.

The majority of patients should avoid the temptation of exploring drug coupons.

 is an internal medicine physician and on the Board of Contributors at USA Today.  He is founder and editor of KevinMD.com, also on FacebookTwitterGoogle+, and LinkedIn.

 

 

 

December 15, 2012 Posted by | health care | , , , | 1 Comment

   

%d bloggers like this: